• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大规模的癌症特异性蛋白质-DNA 相互作用网络。

A large-scale cancer-specific protein-DNA interaction network.

机构信息

https://ror.org/05qwgg493 Biology Department, Boston University, Boston, MA, USA.

https://ror.org/05qwgg493 Molecular Biology, Cellular Biology and Biochemistry Program, Boston University, Boston, MA, USA.

出版信息

Life Sci Alliance. 2024 Jul 16;7(10). doi: 10.26508/lsa.202402641. Print 2024 Oct.

DOI:10.26508/lsa.202402641
PMID:39013578
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11252446/
Abstract

Cancer development and progression are generally associated with gene dysregulation, often resulting from changes in the transcription factor (TF) sequence or expression. Identifying key TFs involved in cancer gene regulation provides a framework for potential new therapeutics. This study presents a large-scale cancer gene TF-DNA interaction network, as well as an extensive promoter clone resource for future studies. Highly connected TFs bind to promoters of genes associated with either good or poor cancer prognosis, suggesting that strategies aimed at shifting gene expression balance between these two prognostic groups may be inherently complex. However, we identified potential for oncogene-targeted therapeutics, with half of the tested oncogenes being potentially repressed by influencing specific activators or bifunctional TFs. Finally, we investigate the role of intrinsically disordered regions within the key cancer-related TF ESR1 in DNA binding and transcriptional activity, and found that these regions can have complex trade-offs in TF function. Altogether, our study broadens our knowledge of the TFs involved in cancer gene regulation and provides a valuable resource for future studies and therapeutics.

摘要

癌症的发生和发展通常与基因失调有关,这通常是由于转录因子 (TF) 序列或表达的变化引起的。鉴定参与癌症基因调控的关键 TF 为潜在的新治疗方法提供了一个框架。本研究提出了一个大规模的癌症基因 TF-DNA 相互作用网络,以及一个用于未来研究的广泛的启动子克隆资源。高度连接的 TF 与与良好或不良癌症预后相关的基因的启动子结合,这表明旨在改变这两个预后组之间基因表达平衡的策略可能本质上很复杂。然而,我们确定了针对致癌基因的治疗方法的潜力,其中一半经过测试的致癌基因可能通过影响特定的激活剂或双功能 TF 被抑制。最后,我们研究了关键癌症相关 TF ESR1 中内在无序区域在 DNA 结合和转录活性中的作用,发现这些区域在 TF 功能中可能存在复杂的权衡。总的来说,我们的研究拓宽了我们对参与癌症基因调控的 TF 的认识,并为未来的研究和治疗提供了有价值的资源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3da/11252446/b5b778441ceb/LSA-2024-02641_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3da/11252446/bb73e0b0b363/LSA-2024-02641_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3da/11252446/4029acbdfdf9/LSA-2024-02641_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3da/11252446/b5acb94048aa/LSA-2024-02641_FigS1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3da/11252446/a3ba9285019d/LSA-2024-02641_FigS2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3da/11252446/a388eab234d5/LSA-2024-02641_FigS3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3da/11252446/c3b817e8f955/LSA-2024-02641_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3da/11252446/d9b44b74ad4a/LSA-2024-02641_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3da/11252446/b5b778441ceb/LSA-2024-02641_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3da/11252446/bb73e0b0b363/LSA-2024-02641_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3da/11252446/4029acbdfdf9/LSA-2024-02641_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3da/11252446/b5acb94048aa/LSA-2024-02641_FigS1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3da/11252446/a3ba9285019d/LSA-2024-02641_FigS2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3da/11252446/a388eab234d5/LSA-2024-02641_FigS3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3da/11252446/c3b817e8f955/LSA-2024-02641_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3da/11252446/d9b44b74ad4a/LSA-2024-02641_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c3da/11252446/b5b778441ceb/LSA-2024-02641_Fig5.jpg

相似文献

1
A large-scale cancer-specific protein-DNA interaction network.大规模的癌症特异性蛋白质-DNA 相互作用网络。
Life Sci Alliance. 2024 Jul 16;7(10). doi: 10.26508/lsa.202402641. Print 2024 Oct.
2
A large-scale cancer-specific protein-DNA interaction network.一个大规模的癌症特异性蛋白质 - DNA 相互作用网络。
bioRxiv. 2024 Jan 29:2024.01.24.577099. doi: 10.1101/2024.01.24.577099.
3
Ligand-Free Estrogen Receptor (ESR1) as Master Regulator for the Expression of CYP3A4 and Other Cytochrome P450 Enzymes in the Human Liver.配体非依赖型雌激素受体(ESR1)作为人肝中 CYP3A4 和其他细胞色素 P450 酶表达的主调控因子。
Mol Pharmacol. 2019 Oct;96(4):430-440. doi: 10.1124/mol.119.116897. Epub 2019 Aug 9.
4
Distinct and competitive regulatory patterns of tumor suppressor genes and oncogenes in ovarian cancer.卵巢癌中肿瘤抑制基因和癌基因的独特且竞争性的调控模式。
PLoS One. 2012;7(8):e44175. doi: 10.1371/journal.pone.0044175. Epub 2012 Aug 30.
5
Understanding the transcriptional regulation of cervix cancer using microarray gene expression data and promoter sequence analysis of a curated gene set.利用微阵列基因表达数据和经过精心筛选的基因集的启动子序列分析来理解宫颈癌的转录调控。
Gene. 2014 Feb 10;535(2):233-8. doi: 10.1016/j.gene.2013.11.028. Epub 2013 Nov 27.
6
Benchmark and integration of resources for the estimation of human transcription factor activities.用于估计人类转录因子活性的资源的基准测试和整合。
Genome Res. 2019 Aug;29(8):1363-1375. doi: 10.1101/gr.240663.118. Epub 2019 Jul 24.
7
TF-RBP-AS Triplet Analysis Reveals the Mechanisms of Aberrant Alternative Splicing Events in Kidney Cancer: Implications for Their Possible Clinical Use as Prognostic and Therapeutic Biomarkers.TF-RBP-AS三联体分析揭示了肾癌中异常可变剪接事件的机制:其作为预后和治疗生物标志物的潜在临床应用意义
Int J Mol Sci. 2021 Aug 16;22(16):8789. doi: 10.3390/ijms22168789.
8
Genetic variations of DNA bindings of FOXA1 and co-factors in breast cancer susceptibility.乳腺癌易感性中 FOXA1 及其共同因子的 DNA 结合的遗传变异。
Nat Commun. 2021 Sep 13;12(1):5318. doi: 10.1038/s41467-021-25670-9.
9
A comprehensive survey for human transcription factors on expression, regulation, interaction, phenotype and cancer survival.人类转录因子在表达、调控、相互作用、表型和癌症生存方面的全面调查。
Brief Bioinform. 2021 Sep 2;22(5). doi: 10.1093/bib/bbab002.
10
Disrupted cooperation between transcription factors across diverse cancer types.不同癌症类型中转录因子之间的合作受到破坏。
BMC Genomics. 2016 Aug 5;17:560. doi: 10.1186/s12864-016-2842-8.

引用本文的文献

1
CRISPR screening approaches in breast cancer research.乳腺癌研究中的CRISPR筛选方法。
Cancer Metastasis Rev. 2025 Jul 12;44(3):59. doi: 10.1007/s10555-025-10275-1.
2
Widespread variation in molecular interactions and regulatory properties among transcription factor isoforms.转录因子亚型之间分子相互作用和调控特性的广泛差异。
Mol Cell. 2025 Apr 3;85(7):1445-1466.e13. doi: 10.1016/j.molcel.2025.03.004. Epub 2025 Mar 26.

本文引用的文献

1
Transcription factors in the development and treatment of immune disorders.转录因子在免疫紊乱的发生发展及治疗中的作用
Transcription. 2025 Feb;16(1):118-140. doi: 10.1080/21541264.2023.2294623. Epub 2023 Dec 15.
2
Paired yeast one-hybrid assays to detect DNA-binding cooperativity and antagonism across transcription factors.通过酵母双杂交实验检测转录因子之间的 DNA 结合协同作用和拮抗作用。
Nat Commun. 2023 Oct 18;14(1):6570. doi: 10.1038/s41467-023-42445-6.
3
Widespread perturbation of ETS factor binding sites in cancer.癌症中 ETS 因子结合位点的广泛扰动。
Nat Commun. 2023 Feb 17;14(1):913. doi: 10.1038/s41467-023-36535-8.
4
Enhanced Yeast One-Hybrid Assays to Study Protein-DNA Interactions.增强型酵母单杂交分析用于研究蛋白质-DNA 相互作用。
Methods Mol Biol. 2023;2599:11-20. doi: 10.1007/978-1-0716-2847-8_2.
5
Transcription factor antagonism regulates heterogeneity in embryonic stem cell states.转录因子拮抗作用调节胚胎干细胞状态的异质性。
Mol Cell. 2022 Dec 1;82(23):4410-4427.e12. doi: 10.1016/j.molcel.2022.10.022. Epub 2022 Nov 9.
6
Cis-regulatory chromatin loops analysis identifies GRHL3 as a master regulator of surface epithelium commitment.顺式调控染色质环分析确定GRHL3为表面上皮细胞定向分化的主要调节因子。
Sci Adv. 2022 Jul 15;8(28):eabo5668. doi: 10.1126/sciadv.abo5668. Epub 2022 Jul 13.
7
Compatibility rules of human enhancer and promoter sequences.人类增强子和启动子序列的兼容性规则。
Nature. 2022 Jul;607(7917):176-184. doi: 10.1038/s41586-022-04877-w. Epub 2022 May 20.
8
Thyroid Carcinoma with NSD3::NUTM1 Fusion: a Case with Thyrocyte Differentiation and Colloid Production.甲状腺癌伴 NSD3::NUTM1 融合:具有甲状腺细胞分化和胶体产生的病例。
Endocr Pathol. 2022 Jun;33(2):315-326. doi: 10.1007/s12022-021-09700-2. Epub 2022 Jan 8.
9
Compendium of human transcription factor effector domains.人类转录因子效应结构域手册。
Mol Cell. 2022 Feb 3;82(3):514-526. doi: 10.1016/j.molcel.2021.11.007. Epub 2021 Dec 3.
10
KRAS mutation: from undruggable to druggable in cancer.KRAS 突变:从不可用药到癌症的可用药。
Signal Transduct Target Ther. 2021 Nov 15;6(1):386. doi: 10.1038/s41392-021-00780-4.